Barclays lowered the firm’s price target on Aveanna (AVAH) to $9.50 from $11 and keeps an Overweight rating on the shares. The firm revised models in the healthcare facilities and managed care group following the Q4 reports.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVAH: